Tolero Pharmaceuticals, Inc., a clinical-stage company focused on developing novel therapeutics for hematological and oncological diseases, today presented new data from the ongoing Phase 2 Zella...

New data from a post hoc analysis of the Phase II SUSTAIN study of crizanlizumab -- a once-a-month, humanized anti-P-selectin monoclonal antibody infusion being investigated for the treatment of...

Today, the Multiple Myeloma Research Foundation (MMRF) announced new discoveries driven by its landmark CoMMpass StudySM into defining myeloma subtypes, identifying novel therapeutic targets for...

Dairy innovators JoeFroyo are proud to announce their lactose-free, probiotic Functional Cold Brew™ product is a semi-finalist in the New Beverage Showdown at BevNET Live Winter 2018, taking...

Community Brands, the leading provider of cloud-based software for associations, nonprofits, schools and faith-based organizations, today released an all-new feature set that includes the ability...